Home / Resources / CBG vs CBD — Margin Math

CBG vs CBD — The Margin Math for Retailers

CBG costs more per gummy than CBD. That higher input cost can translate to a stronger per-unit margin at retail — if you price and position the SKU correctly.

1. Cost-of-Goods: CBG Isolate vs CBD Isolate

CBD isolate has been a commodity ingredient since 2019. Spot prices have compressed significantly since the early days of the category. A licensed hemp manufacturer today can source pharmaceutical-grade CBD isolate at prices that allow a 10mg gummy to be manufactured at a very low per-unit cost. That's the commodity reality CBD buyers are working with.

CBG isolate is a different supply picture. CBG (cannabigerol) is the biosynthetic precursor to CBD, THC, and other cannabinoids in the hemp plant. In a mature hemp plant, most of the CBGA has already converted to other cannabinoids — so a grower has to either harvest very early or grow a CBG-specific cultivar. CBG-specific cultivars are less widely planted than CBD-dominant strains. Yields of CBG isolate per acre of biomass are lower. Extraction and isolation runs cost more per kilogram of finished isolate than CBD isolation from the same biomass weight.

The practical result: at any given volume tier, a 10mg CBG isolate gummy costs more to manufacture than a 10mg CBD gummy. At the Starter tier (500–2,499 units), our CBG gummies run $0.24 per unit versus lower CBD pricing. The input cost differential is real. What matters for retail buyers is what happens to that cost differential on the shelf.

2. Shelf Price Elasticity — Focus Aisle vs General Wellness

CBD has a price ceiling problem. Consumers have trained themselves to expect CBD gummies at commodity price points — particularly in general-wellness aisles. A 30-count CBD gummy at $30–$35 is a crowded, competitive shelf segment. Buyers in that segment are price-comparing and they know approximately what they should pay.

CBG doesn't live in that same shelf segment. Retailers who merchandise CBG next to L-theanine, lion's mane, and rhodiola — rather than next to melatonin and generic CBD — are operating in a different price conversation. The nootropic and focus aisle carries retail prices $15–$25 higher for the same unit count compared to general wellness. Consumers shopping that aisle are paying for category expertise and specificity, not the lowest milligram-per-dollar ratio.

That shelf adjacency gives CBG price protection that plain CBD doesn't have. A 30-count CBG gummy at $45–$55 does not face the same consumer resistance that a $45 CBD gummy would on a typical wellness shelf. The category itself justifies a premium frame.

3. Per-Unit Margin Example: 5mg, 10mg, 20mg CBG

The following uses illustrative retail price ranges based on what buyers in the focus-supplement aisle commonly achieve. These are not guaranteed outcomes — your market, your shelf, your customer mix will all affect realized retail prices.

Illustrative only. Wholesale pricing from Steve's Goods at the 500–2,499 Starter tier. Retail prices based on typical observed range in focus-supplement retail. Your margin depends on your channel, your retail price, and your volume tier. See full wholesale pricing.

4. When CBG Cannibalizes vs Expands a CBD Line

The substitution risk is real but overestimated by most buyers who haven't run both categories. Here's the pattern we see: if a retailer introduces CBG gummies in the same shelf position as their existing CBD gummies at approximately the same price, some CBD customers do migrate. Cannibalization happens when the positioning is unclear.

The retailers who see category expansion instead of cannibalization do three things differently. First, they merchandise CBG in a distinct shelf position — focus and daytime — rather than mixing it into a general CBD section. Second, they price CBG at a meaningful premium to CBD, reinforcing the idea that these are different products for different use cases. Third, they train staff to explain the functional positioning difference (daytime / nootropic adjacency vs general wellness) rather than calling CBG a "stronger CBD."

When CBG is positioned correctly, the buyer who buys CBG is often not the same buyer who was previously buying CBD. They're coming off the L-theanine or lion's mane shelf — or they're a CBD buyer who was already looking for a daytime-specific option and couldn't find one. That is additive basket behavior, not a substitution.

5. Bundling Strategy

The strongest retail bundling pattern for CBG is the daytime-nighttime pair. CBG (daytime focus) alongside a CBN gummy (nighttime rest) gives a retailer a two-SKU story that anchors in the customer's daily routine. The pair gives retail staff an easy script: one for morning, one for night. It sells faster than either SKU alone because customers who buy one come back for the other.

A second bundling pattern that performs well is CBG plus a lion's mane or L-theanine SKU — either as adjacent shelf placement or as a literal bundle pack. This positions CBG squarely in the nootropic category rather than the hemp category. If your store already carries nootropic supplements, CBG fits that adjacency better than a standard hemp-wellness display.

For wholesale buyers with multiple retail doors, the most common entry pattern we see is a 10mg CBG isolate SKU on the Starter tier (500–999 units per door) to test sell-through, with a reorder and a 1:1 CBD+CBG blend added on the second order. The blend SKU mix question is covered separately.

These statements have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease. All CBG products are hemp-derived. Hemp-derived, state rules vary — check your state.